Dominus Investment

Medytox is a Korea-based biopharmaceutical company focused on the development, manufacture, and marketing of medical aesthetics and therapeutic products. Its primary offerings include type-A botulinum toxin, which is used to treat conditions such as blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis, and infantile cerebral palsy. Medytox markets its products under various brand names, including Neuronox and Siax. The company distributes its products both domestically and internationally, reaching markets in Japan, China, Russia, and Europe. In addition to its pharmaceutical products, Medytox is involved in providing information services related to public and financial aspects of its operations.